This website uses cookies to enhance the user experience.
N

NORSVIN R&D AS916 197 691

Research
Limited company
Storhamargata 44 2317 HAMAR, Norge

NORSVIN R&D AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
9 years
since Nov 6, 2015
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
300
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
24,006,867
NOK
Annual total result 2023
2,199,561
NOK
Total equity 2023
12,774,872
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
P
PRICEWATERHOUSECOOPERS AS
Accountant-
Last update: Jul 8, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
N
NORSVIN SA
Ordinary shares
300
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 250,677,063
    Operating profit 2023: NOK 17,205,254
    Employees: 101

Financials

in NOK

Summary

Year202320222021
Total operating income
24,006,867
27,642,274
24,035,138
Annual Total Result
2,199,561
1,411,463
-202,966
Total assets
21,386,126
18,338,429
13,687,844
Total liabilities
8,611,255
7,763,118
4,523,996
Total equity
12,774,872
10,575,311
9,163,848

P&L

Year202320222021
Total operating income
24,006,867
27,642,274
24,035,138
Total operating costs
22,184,954
26,327,631
24,246,748
Operating result
1,821,913
1,314,643
-211,610
Financial income/costs
377,647
96,820
8,644
Profit before tax
2,199,561
1,411,463
-202,966
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
2,199,561
1,411,463
-202,966

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
21,386,126
18,338,429
13,687,844
Total assets
21,386,126
18,338,429
13,687,844
Short term debt
8,611,255
7,763,118
4,523,996
Long term debt
0
0
0
Total liabilities
8,611,255
7,763,118
4,523,996
Contributed capital
30,000
30,000
30,000
Retained earnings
12,744,872
10,545,311
9,133,848
Total equity
12,774,872
10,575,311
9,163,848
Total equity and liabilities
21,386,126
18,338,429
13,687,844

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology